CCL2 and atherosclerosis: In humans, MCP-1 has been detected in atherosclerotic plaques [9], and MCP-1 plasma concentrations have been found to be relatively high in patients with CVD risk factors [10], suggesting that MCP-1 may play a critical role at multiple stages of atherosclerosis [11,12].